The glucose tolerance test, but not HbA1c, remains the gold standard in identifying unrecognized diabetes mellitus and impaired glucose tolerance in hypertensive subjects

Angiology

Volumn 56, Issue 5, 2005, Pages 571-579

  Salmasi, Abdul Majeed ^a,b   Dancy, Mark ^a,b  

^a Central Middlesex Hospital ^*

^b CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORAL GLUCOSE TOLERANCE TEST; RACE DIFFERENCE; RELIABILITY; SMOKING; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 25644431966     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970505600508     Document Type: Article

References (31)

1. Clark CM Jr, Perry RC: Type 2 diabetes and macrovascular disease: Epidemiology and etiology. Am Heart J 138:5330-5333, 1999.
2. Fuller JH, Shipley MJ, Rose G, et al: Coronary heart disease risk and impaired glucose tolerance: The Whitehall study. Lancet 1:1373-1376, 1980.
3. Stamler J, Vaccaro O, Neaton JD, et al: Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993.
4. Morrish NJ, Stevens LK, Head J, et al: A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates. Diabetologia 33:538-541, 1990.
5. Califf RM: Insulin resistance: A global epidemic in need of effective therapies. Eur Heart J 5:C13-C18, 2003.
6. Sobel BE, Frye R, Detre KM: Burgeoning dilemmas in the management of diabetes and cardiovascular disease: Rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation 107:636-642, 2003.
7. Koon-Hou M, Faxon DP: Clinical studies on coronary revascularization in patients with type 2 diabetes. Eur Heart J 24:1087-1103, 2003.
8. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998.
9. Anand SS, Razak F, Vuksan V, et al: Diagnostic strategies to detect glucose intolerance in a multi-ethnic population. Diabetes Care 26:290-296, 2003.
10. Williams DR, Wareham NJ, Brown DC, et al: Undiagnosed glucose intolerance in the community: The Isle of Ely Diabetes project. Diabet Med 12:30-35, 1995.
11. Kannel WB: Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA 275:1571-1576, 1996.
12. Kannel WB: Potency of vascular risk factors as the basis for antihypertensive therapy. Eur Heart J 13(suppl G):34-42, 1992.
13. Bur A, Herkner H, Woisetschlager C, et al: Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension? Am J Hypertens 16:297-301, 2003.
14. Tai MM: A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152-154, 1994.
15. Ashby JP, Deacon AC, Frier BM: Glycosylated hemoglobin. I. Measurement and clinical interpretation. Diabet Med 2:86-87, 1985.
16. Davidson MB, Schriger DL, Peters AL, et al: Relationship between fasting plasma and glycosylated hemoglobin: Potential for false-positive diagnosis of type 2 diabetes using new diagnostic criteria. JAMA 281:1203-1210, 1999.
17. 1999 World Health Organisation-International Society of Hypertension guidelines for the management of Hypertension. J Hypertens 17:151-183, 1999.
18. Nakagami T, Qiao Q, Tuomilehto J, et al: The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. Diabet Res Clin Pract 55:35-43, 2002.
19. Barree-Connor E, Ferrara A: Isolated postchallenge hyperglycaemia and the risk of fatal cardiovascular disease in older women and men: The Rancho Bernardo study. Diabetes Care 21:1236-1239, 1998.
20. Shaw JE, de Courten M, Boyko EJ, et al: Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care 22:762-766, 1999.
21. The DECODE study group on behalf of the European Diabetes Epidemiology Group: Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 22:647-654, 1999.
22. Vaccaro O, Ruffa G, Imperatore G, et al: Risk of diabetes in the new diagnostic category of impaired fasting glucose. Diabetes Care 22:1490-1493, 1999.
23. Shaw JE, Zimmet PZ, de Couten M, et al: Impaired fasting glucose or impaired glucose tolerance? Diabetes Care 22:399-402, 1999.
24. Weinberger MH, Fineberg NS, Fineberg EF: The influence of blood pressure and carbohydrate tolerance on vascular compliance in humans. Am J Hypertension 15:678-682, 2002.
25. Pyorala M, Miettinen H, Halonen P, et al: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men, the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20:538-544, 2000.
26. Unwin N, Shaw J, Zimmet P, et al: Impaired glucose tolerance and impaired fasting glycaemia: The current status on definition and intervention. Diabet Med 19:708-723, 2002.
27. Tominaga M, Eguchi H, Manaka H, et al: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Fungata Diabetes Study. Diabetes Care 22:920-924, 1999.
28. Dinneen SF, Maldonado D III, Leibson CL, et al: Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 21:1408-1413, 1998.
29. Sowers JR, Epstein M: Diabetes mellitus and associated hypertension, vascular disease and nephropathy. Hypertension 26:869-879, 1995.
30. Charles MA, Fontbonne A, Thibult N, et al: Risk factors for NIDDM in white population: Paris Prospective Study. Diabetes 40:796-799, 1991.
31. Daskalopoulou SS, Mikhailidis DP, Elisaf M: Prevention and treatment of the metabolic syndrome. Angiology 55:589-612, 2004.